China Antibody-B (03681.HK) Completes Sale of Suzhou Property and Facilities

Zhitong Finance APP News, China Antibody-B (03681.HK) issued an announcement regarding the subsidiary's proposed sale of Suzhou properties and facilities for RMB 280 million. The Board is pleased to announce that all conditions precedent set out in the sale and purchase agreement have been fulfilled, and the disposal was completed on November 4, 2026 in accordance with the terms and conditions of the sale and purchase agreement. Upon completion, the target assets are no longer owned by the seller, and the Company no longer has any interest in the target assets.